drugset / Trial / NCT02476253

Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill

NCT02476253

Phase 3 Completed 400 enrolled University Hospital, Montpellier
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the present study is to compare the adjunct treatment of metabolic or mixed severe acidosis in the critically ill using Sodium Bicarbonate as a buffer to increase the plasma pH vs no buffering therapy. The study is a randomized multiple center clinical trial with the outcome as a primary endpoint.

Timeline

Start
2015-05-05
Primary completion
2017-05-29
Completion
2017-05-29

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 4.2 % Intravenous
Subject sodium bicarbonate Diagnostic / imaging agent 125 ml Intravenous
Subject sodium bicarbonate Diagnostic / imaging agent 250 ml Intravenous

Indications